OZANIMOD
Manner of administration:Oral
Restriction (Streamlined authority code: 16323)
Indication: Multiple sclerosis
Treatment phase: Initial treatment
Restriction (Streamlined authority code: 16301)
Indication: Multiple sclerosis
Treatment phase: Continuing treatment
Quantities & Cost
| Max qty packs | Max qty units | # of repeats | DPMQ | Max safety net | General Patient Charge |
|---|---|---|---|---|---|
| Max qty packs: 1 | Max qty units: 1 | # of repeats: 0 | DPMQ: $560.67 | Max safety net: $25.00 | General Patient Charge: $25.00 |
| Available brands | |||||
| Zeposia | |||||
Manner of administration:Oral
Restriction (Streamlined authority code: 14017)
Indication: Moderate to severe ulcerative colitis
Treatment phase: Dose escalation occurring at initial treatment or re-initiation of treatment
Quantities & Cost
| Max qty packs | Max qty units | # of repeats | DPMQ | Max safety net | General Patient Charge |
|---|---|---|---|---|---|
| Max qty packs: 1 | Max qty units: 1 | # of repeats: 0 | DPMQ: $560.67 | Max safety net: $25.00 | General Patient Charge: $25.00 |
| Available brands | |||||
| Zeposia | |||||